BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20200101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210913
DTEND;VALUE=DATE:20210915
DTSTAMP:20260515T212858
CREATED:20210420T085542Z
LAST-MODIFIED:20210420T085542Z
UID:29854-1631491200-1631663999@www.pharmajournalist.com
SUMMARY:Pre-filled Syringes San Francisco 2021
DESCRIPTION:As part of SMi’s leading Injectables series\, this year’s event will address the key drivers of the pre-filled syringes and combination products industry to give a comprehensive insight into the latest device innovations\, regulatory updates and future insights for the coming year. With the global market for prefilled syringes estimated to exceed $9.7bn by 2025\, the field is evolving at an exponential rate with connectivity and digital health strategies for devices and studies at the forefront. Furthermore\, this event will delve into the key takeaways following the global pandemic and discover how this will be used to enhance future drug delivery device development. \nThis comprehensive overview will explore the changing global market and latest innovations in device design and development for injectable drug delivery. Case studies from leading industry and regulatory experts will explore platform approaches for combination products\, enhanced device design and usability considerations\, change management and compatibility for novel drug products. \nThe two-day agenda offers you peer-to-peer networking with Global Product Managers\, Senior PFS Engineers\, Device Testing Managers\, Heads of Late-Stage PFS Development and many more. \nPlus\, two interactive post conference workshops:  \nA: Connected Devices and Digital Health: How to Navigate the U.S. FDA Usability Engineering Requirements \nWorkshop Leader: Shannon Clark\, CEO\, UserWise \nB: Postmarket Safety Reporting: The Current Regulatory Environment with a Global Impact \nWorkshop Leader: Khaudeja Bano\, Executive Medical Director\, Combination Product Safety Head\, Amgen \nBenefits of attending: \n\nEngage in case studies from big pharma leading experts on smart devices and connected delivery to aid the user experience\nExplore evolving device design and innovations for high volume and high viscous delivery\nDelve into regulatory updates on device development and human factors with insights from industry and regulatory bodies\nUncover how industry is incorporating risk management and controls into early stages for a holistic development process\n\nChairs for 2021: \n\nShannon Clark\, CEO\, UserWise\nPaul Upham\, Head Smart Devices\, Roche/Genentech\n\nFeatured 2021 speakers include: \n\nAlan M. Stevens\, Acting Director – Division of Drug Delivery\, General Hospital\, and Human Factors\, CDRH\, FDA\nGeorge Cusatis\, Director\, Regulatory Affairs\, Merck\nJames Robert Wise\, Associate Senior Consultant Engineer\, Eli Lilly\nJim Leamon\, Director of Biologics Device Development\, Jazz Pharmaceuticals\nScott Surrette\, Manager Combination Product Development\, Regeneron\nJace Blackburn\, Smart Device Engineer\, Roche/Genentech\nAlasdair Young\, Senior Director\, Device Engineering\, Coherus BioSciences\nRachel Poker\, Human Factors Engineering Manager\, Device Development\, AstraZeneca\nYoung Chun\, Associate Director – Lead Human Factors and User Research\, R&D/Medical Devices Center of Excellence\, Takeda\nMehak Mehta\, Scientist II\, Protein Drug Product Development\, Biogen\nAlie Jahangir\, Sr. Principle Engineer\, Combination Products and Emerging Technologies\, Janssen Pharmaceuticals\nSindhuja Kuchibhatla\, Device Development Engineer\, New Technologies Management\, Regeneron Pharmaceuticals\n\n\nEARLY-BIRD RATES: \n\nBOOK BY 28TH MAY AND SAVE £200\nBOOK BY 30TH JUNE AND SAVE £100\n\nAdditional Contact Info:\nT: +44 (0)20 7827 6088\nE: hsidhu@smi-online.co.uk \nLinkedIn: @SMi Pharma\nTwitter: #smipfsusa
URL:https://www.pharmajournalist.com/event/pre-filled-syringes-san-francisco-2021/
LOCATION:Hyatt Centric Fisherman’s Wharf\, San Francisco (Virtual Attendance Option Available)
ORGANIZER;CN="SMi Group":MAILTO:EVENTS@SMI-ONLINE.CO.UK
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20210914
DTEND;VALUE=DATE:20210917
DTSTAMP:20260515T212858
CREATED:20210609T105252Z
LAST-MODIFIED:20210609T105252Z
UID:30495-1631577600-1631836799@www.pharmajournalist.com
SUMMARY:Gene Therapy for Metabolic Disorders
DESCRIPTION:More companies and institutions than ever before are embarking on development of gene therapies in metabolic disease\, and they are encountering unique challenges\, from fine-tuning dosing to defining clinically relevant biomarkers. Gene Therapy for Metabolic Disorders will unite large pharma and innovative biotechs to collectively overcome translational drug development barriers to deliver on the transformative promise of gene therapy approaches for patients in need.  \nIncorporating in-depth insights into the leading metabolic disease programs\, this event will ensure that you can optimize dosing to achieve the required enzyme levels without over-expression\, define the necessary parameters for transitioning to first-in-human trials\, and overcome unique challenges encountered in multi-organ systemic gene therapy delivery for complex metabolic indications.  \nDon’t get left behind. Join colleagues from Preclinical\, Translational and Clinical departments of leading companies including AVROBIO\, Freeline Therapeutics and LogicBio to optimize your gene therapy approach and revolutionize the treatment of metabolic diseases. \nTo know more about Gene Therapy for Metabolic Disorders please click here.
URL:https://www.pharmajournalist.com/event/gene-therapy-for-metabolic-disorders/
LOCATION:Digital Event | EDT
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR